Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P20+4+0+0+0
S42-0-3+0+0

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

M
2017-05-24
JUNOJuno Therapeutics, Inc.Flatley Jay TDirP - Purchase$24.76+20,00021,500>999%+$495,217
2017-05-24
HSKAHeska CorpNapolitano Jason ACOO, Chief Strategist, Sec.S - Sale$100.50-5,00032,721-13%-$502,500
2017-05-24
HSKAHeska CorpWisnewski NancyEVP, Diag. Ops, Prod. Dev.S - Sale$100.17-25038,901-1%-$25,042
D
2017-05-23
HSKAHeska CorpMcMahon JohnVP, CFOS - Sale+OE$97.00-5870-100%-$56,940
D
2017-05-23
HSKAHeska CorpWrenn CarolDirS - Sale+OE$96.95-1,6304,544-26%-$158,024
2017-05-24
AMGNAmgen IncPatton Cynthia MSVP, CCOS - Sale$154.40-2,92221,540-12%-$451,164
2017-05-22
EDITEditas Medicine, Inc.Bitterman KevinDirS - Sale$17.00-1,000,0002,797,144-26%-$17,000,000
2017-05-23
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$53.39-10,000107,691-8%-$533,900
D
2017-05-18
NBIXNeurocrine Biosciences IncObrien Christopher FlintCHIEF MEDICAL OFFICERS - Sale+OE$53.32-105,63448,973-68%-$5,632,405
DM
2017-05-18
NBIXNeurocrine Biosciences IncLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$53.63-9,96013,017-43%-$534,155
D
2017-05-18
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale+OE$53.27-10,00013,157-43%-$532,700
2017-05-19
MNTAMomenta Pharmaceuticals IncKaundinya Ganesh VenkataramanSenior VP, ResearchS - Sale$15.90-821489,6290%-$13,054
2017-05-19
MNTAMomenta Pharmaceuticals IncWheeler Craig APresS - Sale$15.83-4,116279,861-1%-$65,156
2017-05-22
MNTAMomenta Pharmaceuticals IncLeicher BruceSVP, GCS - Sale$14.80-859174,3420%-$12,713
DM
2017-05-18
GNCAGenocea Biosciences, Inc.Siber GeorgeDirP - Purchase$6.04+53,3322,017-104%+$322,173
D
2017-05-18
CELZCreative Medical Technology Holdings, Inc.Warbington TimothyPres, CEO, 10%S - Sale+OE$0.45-1,40065,083,5940%-$630
D
2017-05-18
CELZCreative Medical Technology Holdings, Inc.Creative Medical Health Inc.10%S - Sale+OE$0.45-1,40058,616,9270%-$630
M
2017-05-17
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$14.91-4,8001,194,8370%-$71,568
M
2017-05-16
APENApollo Endosurgery, Inc.McClellan William D. Jr.DirP - Purchase$6.33+2,0002,000New+$12,651
M
2017-05-16
APENApollo Endosurgery, Inc.Newton ToddCEOP - Purchase$6.22+2,12130,766+7%+$13,198
DM
2017-05-16
CRSPCrispr Therapeutics AGNovak RodgerCEOS - Sale+OE$16.26-50,0001,215,005-4%-$812,859
2017-05-17
CURNeuralstem, Inc.Daly Richard JCEOP - Purchase$4.00+7,50023,312+47%+$30,000
D
2017-05-16
BTXBiotime IncAndrews Deborah JDirP - Purchase$3.21+2,0004,000+100%+$6,410
DM
2017-05-15
ATRAAtara Biotherapeutics, Inc.McGrath JohnEVP, CFOS - Sale+OE$15.11-4,000117,460-3%-$60,440
D
2017-05-16
ATRAAtara Biotherapeutics, Inc.Gallagher Carol GiltnerDirS - Sale+OE$15.25-1,184103,374-1%-$18,056
2017-05-15
RGNXRegenxbio Inc.Hayden Donald J JrDirS - Sale$19.04-8,5990-100%-$163,725
2017-05-15
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$19.07-3,100110,612-3%-$59,117
D
2017-05-15
ATRAAtara Biotherapeutics, Inc.Haqq ChristopherEVP, R, D, Chief Scientific OfS - Sale+OE$14.99-7,604394,080-2%-$113,984
D
2017-05-16
ATRAAtara Biotherapeutics, Inc.Clark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$15.25-3,873153,000-2%-$59,063
DM
2017-05-15
ATRAAtara Biotherapeutics, Inc.Soffer GadEVP, Chief Strategy OfficerS - Sale+OE$15.16-12,674264,409-5%-$192,098
D
2017-05-15
ONCESpark Therapeutics, Inc.Faga DanielChief Business OfficerS - Sale+OE$56.90-4,5000-100%-$256,050
2017-05-09
AERIAerie Pharmaceuticals IncCagle Gerald D.DirP - Purchase$39.90+1,00012,900+8%+$39,900
2017-05-15
ACORAcorda Therapeutics IncHindman Andrew A.Chief Business Dev. OfficerS - Sale$15.75-7,70446,123-14%-$121,319
2017-05-16
PLXProtalix Biotherapeutics, Inc.Manor MoshePres, CEOP - Purchase$0.81+50,00050,000New+$40,500
M
2017-05-11
SGMOSangamo Therapeutics, IncHerberts Curt A. IIISVP, CBOS - Sale$8.02-2,63937,345-7%-$21,154
2017-05-11
ONCESpark Therapeutics, Inc.Children'S Hospital of Philadelphia FoundationDir, 10%S - Sale$56.27-840,0004,928,707-15%-$47,266,800
D
2017-05-10
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$88.77-1,25027,305-4%-$110,966
D
2017-05-10
TECHBio-Techne CorpLucas Roger CDirS - Sale+OE$110.59-1003,429-3%-$11,059
2017-05-12
NVAXNovavax IncMcManus Michael A JrDirP - Purchase$0.97+20,000277,590+8%+$19,396+8
2017-05-10
MNTAMomenta Pharmaceuticals IncLeicher BruceSVP, GCS - Sale$16.00-347175,2050%-$5,552+1
2017-05-10
MNTAMomenta Pharmaceuticals IncKaundinya Ganesh VenkataramanSenior VP, ResearchS - Sale$16.00-384490,4530%-$6,144+1
2017-05-10
MNTAMomenta Pharmaceuticals IncWheeler Craig APresS - Sale$15.77-1,852561,4540%-$29,206+1
2017-05-11
NVAXNovavax IncDouglas RichardDirP - Purchase$0.93+200,000550,000+57%+$185,780+8
D
2017-05-09
GILDGilead Sciences IncCogan John FrancisDirS - Sale+OE$67.25-9,94352,619-16%-$668,667-1
M
2017-05-10
APENApollo Endosurgery, Inc.Novo A/s10%S - Sale$5.63-105,0001,351,972-7%-$590,703-9
2017-05-11
NVAXNovavax IncMcManus Michael A JrDirP - Purchase$0.84+10,000257,590+4%+$8,400+12
2017-05-09
KITEKite Pharma, Inc.Nussbaum RanDirP - Purchase$69.11+9,8324,582-187%+$679,4740
2017-05-11
NVAXNovavax IncPhillips Barclay ASVP, CFOP - Purchase$0.84+25,00036,612+215%+$20,950+12
2017-05-11
NVAXNovavax IncErck Stanley CPres, CEOP - Purchase$0.84+50,000128,279+64%+$41,980+12
2017-05-08
RGNXRegenxbio Inc.Hayden Donald J JrDirS - Sale$18.35-10,0008,599-54%-$183,500+2
2017-05-08
GNCAGenocea Biosciences, Inc.Poole JonathanCFOS - Sale$6.51-6,21339,247-14%-$40,447-3
DM
2017-05-08
CBPOChina Biologic Products, Inc.Liu Zhijing CbpoCorporate VPS - Sale+OE$116.48-7,5004,611-62%-$873,6380
2017-05-10
KITEKite Pharma, Inc.Jenkinson Paul LCFOP - Purchase$72.59+3,45010,480+49%+$250,427+4
2017-05-09
KITEKite Pharma, Inc.Ruchefsky Steven BDirP - Purchase$69.50+1,400225,426+1%+$97,300+4
D
2017-05-05
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$61.74-14,462636,435-2%-$892,897+1
2017-05-09
KITEKite Pharma, Inc.Bonderman DavidDirP - Purchase$68.94+50,0002,410,034+2%+$3,446,998+4
D
2017-05-05
CRSPCrispr Therapeutics AGNovak RodgerCEOS - Sale+OE$16.92-6161,215,0050%-$10,4260
2017-05-09
KITEKite Pharma, Inc.Belldegrun ArieCOB, Pres, CEOP - Purchase$68.57+17,0003,282,776+1%+$1,165,690+2
2017-05-05
NBIXNeurocrine Biosciences IncNevinny Corinne HDirS - Sale$53.98-5,00034,603-13%-$269,900+2+4
AM
2017-05-03
CRISCuris IncMcNab James RDirS - Sale$2.04-76,276929,688-8%-$155,424-2-1
M
2017-05-03
CRISCuris IncMcNab James RDirS - Sale$2.04-76,276929,688-8%-$155,424-2-1
2017-05-04
HSKAHeska CorpLarson Sharon J.DirP - Purchase$90.00+1,0003,294+44%+$90,000+2+5
DM
2017-05-02
CRSPCrispr Therapeutics AGNovak RodgerCEOS - Sale+OE$16.30-49,3841,215,005-4%-$805,183+2+2
D
2017-05-01
IDRAIdera Pharmaceuticals, Inc.Pillar Invest CorpDir, 10%S - Sale+OE$2.26-450,8150-100%-$1,018,4360-15
2017-05-02
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$55.00-10,000117,691-8%-$550,0000-2
D
2017-05-02
NBIXNeurocrine Biosciences IncGorman Kevin CharlesCEOS - Sale+OE$53.23-21,739332,607-6%-$1,157,1670-2
D
2017-05-01
NBIXNeurocrine Biosciences IncGano KyleChief Business Development OffS - Sale+OE$54.00-15,00073,246-17%-$810,0000-2
D
2017-05-01
KITEKite Pharma, Inc.Kim Helen SusanEVP, Business DevelopmentS - Sale+OE$82.12-2,40018,664-11%-$197,088+3-11
D
2017-05-01
KITEKite Pharma, Inc.Chang David DEVP, R, D, Chief Medical OfficS - Sale+OE$82.09-20,00050,165-29%-$1,641,744+3-11
D
2017-05-01
GILDGilead Sciences IncMartin John CExec COBS - Sale+OE$68.31-73,3333,126,636-2%-$5,009,429+1+1
2017-05-01
GILDGilead Sciences IncAlton Gregg HEVP Comm, Acs ALA, Corp, Med AS - Sale$68.31-5,000112,988-4%-$341,529+1+1
2017-05-01
CRSPCrispr Therapeutics AGDylan-Hyde TylerGCS - Sale$16.61-1,852168,204-1%-$30,753+3+4
D
2017-05-01
RGNXRegenxbio Inc.Hayden Donald J JrDirS - Sale+OE$22.26-30,00018,599-62%-$667,736-2-1
D
2017-05-01
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$88.07-1,50037,029-4%-$132,109+7+2
D
2017-05-01
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$88.74-3,00017,177-15%-$266,208+7+2
2017-05-01
CHRSCoherus Biosciences, Inc.Herman Alan C.Chief Scientific OfficerS - Sale$20.00-11,333379,283-3%-$226,626-10
2017-05-02
HEBHemispherx Biopharma IncRodino Peter W. IIIExec Dir Govt Relations, SecrtP - Purchase$0.63+15,87315,873New+$10,000+2-4
2017-05-02
HEBHemispherx Biopharma IncSpringate Wayne S.SVP of OperationsP - Purchase$0.63+15,87332,514+95%+$10,000+2-4
D
2017-05-01
AVXSAvexis, Inc.Nagendran SukumarSVP, Chief Medical OfficerS - Sale+OE$81.39-1,7800-100%-$144,869-2-5
M
2017-04-28
CRISCuris IncMcNab James RDirS - Sale$2.38-116,708126,276-48%-$278,037-7-19
D
2017-04-28
ONCESpark Therapeutics, Inc.High Katherine ASee RemarksS - Sale+OE$58.06-15,000210,000-7%-$870,900-1-2
2017-05-01
BIIBBiogen Inc.Vounatsos MichelCEOP - Purchase$271.35+1,4022,927+92%+$380,4330-4
2017-05-02
HEBHemispherx Biopharma IncStrayer David RChief Science, Medical OfficerP - Purchase$0.63+7,93741,804+23%+$5,000+6+2
2017-05-02
HEBHemispherx Biopharma IncPascale AdamCFOP - Purchase$0.63+15,87327,389+138%+$10,000+6+2
M
2017-04-27
KITEKite Pharma, Inc.Champsi FarahDirS - Sale$82.75-19,16884,114-19%-$1,586,064-2-2
2017-04-27
BIIBBiogen Inc.Denner Alexander JDirP - Purchase$278.50+73,858392,832+23%+$20,569,4760-3
D
2017-04-27
BLUEBluebird Bio, Inc.Lynch DanielDirS - Sale+OE$90.01-1,0001,400-42%-$90,010-30
2017-04-28
GNMXAevi Genomic Medicine, Inc.Barer Sol JDirP - Purchase$1.57+100,0001,126,700+10%+$156,670+3+3
DM
2017-04-26
CRSPCrispr Therapeutics AGKulkarni SamarthChief Business OfficerS - Sale+OE$16.76-5,481134,047-4%-$91,8390-2
M
2017-04-26
CRSPCrispr Therapeutics AGDylan-Hyde TylerGCS - Sale$16.78-21,639170,056-11%-$363,0770-2
D
2017-04-25
KITEKite Pharma, Inc.Butitta Cynthia MCOOS - Sale+OE$81.85-15,000117,795-11%-$1,227,690-1-2
AM
2017-04-20
CRISCuris IncMcNab James RDirS - Sale$2.59-110,3221,269,366-8%-$285,682-4-14
M
2017-04-25
CRISCuris IncMcNab James RDirS - Sale$2.61-146,6941,122,672-12%-$383,019-4-14
2017-04-25
BIIBBiogen Inc.Clancy Paul JEVP, CFOS - Sale$290.00-9,89210,813-48%-$2,868,680-2-2
D
2017-04-25
BLUEBluebird Bio, Inc.Lynch DanielDirS - Sale+OE$86.75-2,0001,400-59%-$173,5000-2
2017-04-27
HEBHemispherx Biopharma IncEquels Thomas K.CEO, PresP - Purchase$0.69+72,464492,919+17%+$50,000-3-1
2017-04-26
GNMXAevi Genomic Medicine, Inc.Barer Sol JDirP - Purchase$1.54+100,0001,026,700+11%+$154,340+6+4
2017-04-24
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale$20.98-15,440125,000-11%-$323,955-1-3
2017-04-24
RGNXRegenxbio Inc.Hayden Donald J JrDirS - Sale$20.98-10,00028,599-26%-$209,800-1-3
2017-04-24
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$21.00-3,100113,712-3%-$65,099-1-3

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top